nivolumab
bms
['prostate']
2/ results: ici showed an 88% reduction in 2y risk of metastasis vs controls (hr=0.12, 95% ci, 0.02-1.0, p=0.05). a major step in the fight against prostate cancer! #aacr23 #cancerresearch
Radiation Oncology Resident @MoffittRadOnc // @ARRO_org Communications Subcommittee // Husband + Girl Dad